Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test
The test uses five biomarkers and proprietary technology to detect amyloid brain plaques in patients with cognitive symptoms.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Watchmaker Genomics Licenses CRISPR Technology to Improve DNA Sequencing Efficiency
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Equipment & Supply Spotlight
Military Health System Now Providing Immediate Lab Results Access Through Patient Portal
Patients at military hospitals and clinics can now access lab results, radiology reports, pathology reports, and clinical notes instantly.
News, Know-How & Standards
Disease Detection & Understanding
FDA Approves PD-L1 Test to Guide Immunotherapy in Ovarian and Related Cancers
PD-L1 testing is now cleared to help identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who may be eligible for anti–PD-1 therapy.
